On Emergent OTC Naloxone Switch, Tight Timeline For FDA Decision Following Advisory Committee

NDAC, AADPAC Meeting 15 February, PDUFDA Date 29 March For Emergent’s Proposal

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.